Skip to content
Disability News Wire
More Better Faster News and Information for the Greater Disability Community and their Allies
Menu
Subscribe
Write a Letter to the Editor
Your Voices
Write a Letter to the Editor
Articles
Default Accessible (#DefaultAccessible)
Disability Sports
Disability Fitness and Health
Disability Glossary
Not-for-Profit News
Newsletters and Blogs
Press Releases
Add an Action
Podcasts
Video
About
Business Inquiries
Contact Us
Anonymous Comment
FAQ
Suggest Articles, Podcasts, and Videos
Write for us
Your email address
Try our newsletter, you can cancel anytime
Your Top Issues
ImmunoRisk - COVID, Evusheld, and Protecting Immunocommpromised Americans
•
MyChairMyRepair - Right to Repair Wheelchairs
• DefaultAccessible • DisabilityEconomy • BetterIDEA • UniversalDisabilityServicesInsurance •
Disability and the Invasion of the Ukraine
Your voice matters - Share your experiences, concerns, suggestions, comments, and insights.
We want to hear from you
Steve Bryson PhD
Articles, Newsletters, Podcasts, and Video
MicroRNAs in Blood May Predict Spinzara Response in Type 1 Patients
2022-06-20
more
MicroRNAs in Blood May Predict Spinzara Response in Type 1 Patients
2022-06-20
more
Higher Spinraza Dose May Be More Effective, Modeling Study Predicts
2022-06-10
more
Combining Evaluation Tools May Detect Early Signs of SMA: Study
2022-06-06
more
MicroRNAs Can Predict Response to Spinraza, Study Suggests
2022-05-27
more
Disease Severity May Be Impacted by SMN Protein in Rare SMA Cases
2022-05-06
more
Combining Therapies May Improve Efficacy in SMA: Mouse Model
2022-04-22
more
Spinraza Most Effective in Younger Type 1 Children: Real-world Study
2022-04-15
more
Same Mutation Causes SMABF2 in 2 Unrelated Infants, Case Study Says
2022-04-08
more
2 Spinraza Trials Now Enrolling, With ASCEND Testing Higher Dose
2022-03-02
more
1
2
3
4
Next »
